相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sheep cheese naturally enriched in α-linolenic, conjugated linoleic and vaccenic acids improves the lipid profile and reduces anandamide in the plasma of hypercholesterolaemic subjects
Stefano Pintus et al.
BRITISH JOURNAL OF NUTRITION (2013)
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects
Tiziana Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
Cristoforo Silvestri et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids
Martin Rossmeisl et al.
PLOS ONE (2012)
Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: Impact of nonalcoholic fatty liver disease
Mohammed M. H. Al-Gayyar et al.
PHARMACEUTICAL BIOLOGY (2012)
Role of ω3 Longchain Polyunsaturated Fatty Acids in Reducing Cardio- Metabolic Risk Factors
Mahinda Y. Abeywardena et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia
Ann C. Skulas-Ray et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Monoglyceride Lipase Deficiency in Mice Impairs Lipolysis and Attenuates Diet-induced Insulin Resistance
Ulrike Taschler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells
Heather L. Hutchins et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Elucidation of Phosphatidylcholine Composition in Krill Oil Extracted from Euphausia superba
Bjorn Winther et al.
LIPIDS (2011)
Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity
Dick C. Chan et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Effect of dietary fat on endocannabinoids and related mediators: Consequences on energy homeostasis, inflammation and mood
Sebastiano Banni et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients
Giovanni Annuzzi et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
V. Di Marzo et al.
DIABETOLOGIA (2009)
Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats
Barbara Batetta et al.
JOURNAL OF NUTRITION (2009)
The endocannabinoid system in obesity and type 2 diabetes
V. Di Marzo
DIABETOLOGIA (2008)
Dixon techniques for water and fat imaging
Jingfei Ma
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins
Maxwell A. Ruby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypertriglyceridemia and cardiovascular risk reduction
Terry A. Jacobson et al.
CLINICAL THERAPEUTICS (2007)
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Matthias Blueher et al.
DIABETES (2006)
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
Isabel Matias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)